Security key
00773U108
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)
CUSIP: 00773U108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,163,711
- Total 13F shares
- 94,361,848
- Share change
- -784,032
- Total reported value
- $1,022,948,988
- Put/Call ratio
- 159%
- Price per share
- $10.84
- Number of holders
- 152
- Value change
- -$6,881,994
- Number of buys
- 73
- Number of sells
- 75
Report period
Q4 2020
Institutions
152
Top holders
10
ADVM full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Adverum Biotechnologies, Inc. SEC filings
Adverum Biotechnologies, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00773U108
Recent filing periods:
Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
42%
|
9,410,860
|
$96,932,000 | — | 30 Sep 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
36%
|
8,000,000
|
$82,400,000 | — | 30 Sep 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
33%
|
7,234,764
|
$74,518,000 | — | 30 Sep 2020 | |
| Versant Venture Management, LLC |
13F
|
Company |
32%
|
7,003,892
|
$72,140,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
31%
|
6,802,150
|
$70,062,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
25%
|
5,627,389
|
$57,962,000 | — | 30 Sep 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
21%
|
4,584,344
|
$47,219,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
20%
|
4,381,163
|
$45,126,000 | — | 30 Sep 2020 | |
| Sonic Fund II, L.P. |
13F
|
Company |
19%
|
4,109,867
|
$42,332,000 | — | 30 Sep 2020 | |
| Casdin Capital, LLC |
13F
|
Company |
12%
|
2,750,000
|
$28,325,000 | — | 30 Sep 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
11%
|
2,404,439
|
$24,766,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
10%
|
2,274,591
|
$23,428,000 | — | 30 Sep 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
8.4%
|
1,871,770
|
$19,280,000 | — | 30 Sep 2020 | |
| Artal Group S.A. |
13F
|
Company |
8.1%
|
1,800,000
|
$18,540,000 | — | 30 Sep 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.8%
|
1,500,000
|
$15,450,000 | — | 30 Sep 2020 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
6.5%
|
1,437,028
|
$14,801,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.9%
|
1,296,936
|
$13,358,000 | — | 30 Sep 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
5.2%
|
1,161,375
|
$11,962,000 | — | 30 Sep 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
4.8%
|
1,062,791
|
$10,947,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.8%
|
1,061,065
|
$10,929,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.8%
|
1,055,133
|
$10,868,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
4.7%
|
1,040,815
|
$10,721,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.3%
|
958,574
|
$9,873,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4.1%
|
918,200
|
$9,457,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
4.1%
|
911,412
|
$9,387,000 | — | 30 Sep 2020 | |
| WS MANAGEMENT LLLP |
13F
|
Company |
3.9%
|
858,000
|
$8,837,000 | — | 30 Sep 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
3.8%
|
840,504
|
$8,657,191 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
3.5%
|
774,442
|
$7,977,000 | — | 30 Sep 2020 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
2.8%
|
625,000
|
$6,438,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.6%
|
572,682
|
$5,899,000 | — | 30 Sep 2020 | |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) |
13F
|
Company |
2.2%
|
480,000
|
$4,944,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
436,588
|
$4,497,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
422,544
|
$4,352,000 | — | 30 Sep 2020 | |
| BARCLAYS PLC |
13F
|
Company |
1.8%
|
396,025
|
$4,081,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.8%
|
396,011
|
$4,079,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.7%
|
386,698
|
$3,983,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.7%
|
378,598
|
$3,956,000 | — | 30 Sep 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.7%
|
369,716
|
$3,808,000 | — | 30 Sep 2020 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.6%
|
364,349
|
$3,753,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
332,083
|
$3,421,000 | — | 30 Sep 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
1.4%
|
303,575
|
$3,127,000 | — | 30 Sep 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.2%
|
273,201
|
$2,814,000 | — | 30 Sep 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
1.2%
|
270,091
|
$2,782,000 | — | 30 Sep 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
1.1%
|
250,077
|
$2,576,000 | — | 30 Sep 2020 | |
| CITIGROUP INC |
13F
|
Company |
1%
|
222,628
|
$2,293,000 | — | 30 Sep 2020 | |
| NORGES BANK |
13F
|
Company |
1%
|
221,789
|
$2,284,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.91%
|
200,806
|
$2,068,000 | — | 30 Sep 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.83%
|
184,571
|
$1,901,081 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.81%
|
178,779
|
$1,841,000 | — | 30 Sep 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.73%
|
162,438
|
$1,674,000 | — | 30 Sep 2020 |
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2020
As of 31 Dec 2020,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,361,848 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, BlackRock Inc., ORBIMED ADVISORS LLC, Sonic Fund II, L.P., Versant Venture Management, LLC, VANGUARD GROUP INC, STATE STREET CORP, and Casdin Capital, LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
158
Q4 2020 holders
152
Holder diff
-6
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.